23-Feb-2024 | BC | Announcement under regulation 30 for re-appointment of Managing Director. | 01-Apr-2024 | |
06-Feb-2024 | BC | Avi Products India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Consider approve and take on record the | 14-Feb-2024 | |
01-Nov-2023 | BC | Avi Products India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-audited Financial Results of the Comp | 08-Nov-2023 | |
06-Nov-2023 | BC | Trading members of the Exchange are hereby informed that the under mentioned new securities of AVI PRODUCTS INDIA LIMITED (Scrip Code - 523896) are listed and permitted to trade on the Exchange with | 07-Nov-2023 | |
29-Sep-2023 | BC | Announcement under Regulation 30(lODR)-allotment of 722230 equity shares under Preferential issue
Revised outcome of Board meeting for unaudited financial result for Q E 30092023
(As Per BSE An | 29-Sep-2023 | |
No Dividends has been declared by AVI-Photochem-Ltd
No Bonus has been declared by AVI-Photochem-Ltd
No Split has been declared by AVI-Photochem-Ltd
RightsNo Rights has been declared by AVI-Photochem-Ltd
Book Closure
01-Apr-2024 | - | Announcement under regulation 30 for re-appointment of Managing Director. |
14-Feb-2024 | - | Avi Products India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Consider approve and take on record the |
08-Nov-2023 | - | Avi Products India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-audited Financial Results of the Comp |
07-Nov-2023 | - | Trading members of the Exchange are hereby informed that the under mentioned new securities of AVI PRODUCTS INDIA LIMITED (Scrip Code - 523896) are listed and permitted to trade on the Exchange with |
29-Sep-2023 | - | Announcement under Regulation 30(lODR)-allotment of 722230 equity shares under Preferential issue
Revised outcome of Board meeting for unaudited financial result for Q E 30092023
(As Per BSE An |